Prenatal diagnosis of hemoglobinopathies: worldwide experience

B. P. Alter

Research output: Contribution to journalArticlepeer-review

Abstract

Prenatal testing for hemoglobinopathies is now a reality, using both fetal blood and fetal fibroblast DNA. New techniques are being developed in the laboratories, and new skills by the obstetricians. Until thalassemia and sickle cell anemia can be cured, they will remain costly public health problems in specific parts of the world. Prenatal testing has provided an additional consideration for the governments and the families in such places, providing an acceptable alternative in many cases.

Original languageEnglish (US)
Pages (from-to)263-274
Number of pages12
JournalBirth Defects: Original Article Series
Volume18
Issue number7
StatePublished - 1982
Externally publishedYes

ASJC Scopus subject areas

  • Developmental Biology
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Prenatal diagnosis of hemoglobinopathies: worldwide experience'. Together they form a unique fingerprint.

Cite this